Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells? DOI Creative Commons

Stephanie Longet,

Stéphane Paul

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Сен. 11, 2023

OPINION article Front. Immunol., 11 September 2023Sec. Immunological Memory Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1216402

Язык: Английский

Tissue‐resident memory T cells and lung immunopathology DOI Creative Commons
In Su Cheon, Young Min Son, Jie Sun

и другие.

Immunological Reviews, Год журнала: 2023, Номер 316(1), С. 63 - 83

Опубликована: Апрель 4, 2023

Rapid reaction to microbes invading mucosal tissues is key protect the host against disease. Respiratory tissue-resident memory T (T

Язык: Английский

Процитировано

34

Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2 DOI Creative Commons
Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy

и другие.

Nature Communications, Год журнала: 2023, Номер 14(1)

Опубликована: Дек. 12, 2023

Type-1 and type-3 interferons (IFNs) are important for control of viral replication; however, less is known about the role Type-2 IFN (IFNγ) in anti-viral immunity. We previously observed that lung infection with Mycobacterium bovis BCG achieved though intravenous (iv) administration provides strong protection against SARS-CoV-2 mice yet drives low levels type-1 IFNs but robust IFNγ. Here we examine ongoing IFNγ responses to pre-established bacterial on disease outcomes two murine models. report required iv induced reduction pulmonary loads, an outcome dependent receptor expression by non-hematopoietic cells. Importantly, show prompts epithelial cells upregulate IFN-stimulated genes reported activity IFNγ-dependent manner, suggesting a possible mechanism protection. Finally, confirm properties demonstrating recombinant cytokine itself challenge when administered intranasally. Together, our data response within protective infection, concurrent or recent infections drive may limit pathogenesis supporting prophylactic uses COVID-19 management.

Язык: Английский

Процитировано

25

Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice DOI Creative Commons
Tianyi Zhang,

Nicholas Magazine,

Michael C. McGee

и другие.

Journal of Medical Virology, Год журнала: 2024, Номер 96(1)

Опубликована: Янв. 1, 2024

Abstract Vaccines have demonstrated remarkable effectiveness in protecting against COVID‐19; however, concerns regarding vaccine‐associated enhanced respiratory diseases (VAERD) following breakthrough infections emerged. Spike protein subunit vaccines for SARS‐CoV‐2 induce VAERD hamsters, where aluminum adjuvants promote a Th2‐biased immune response, leading to increased type 2 pulmonary inflammation animals with infections. To gain deeper understanding of the potential risks and underlying mechanisms VAERD, we immunized ACE2‐humanized mice adjuvanted CpG‐ODN. Subsequently, exposed them increasing doses establish infection. The vaccine elicited robust neutralizing antibody responses, reduced viral titers, host survival. However, infection, vaccinated exhibited severe immunopathology, characterized by significant perivascular infiltration eosinophils CD4 + T cells, along expression Th2/Th17 cytokines. Intracellular flow cytometric analysis revealed systemic Th17 inflammatory particularly pronounced lungs. Our data demonstrate that aluminum/CpG strong Th1‐associated immunity COVID‐19 but also prime which may contribute rapid onset cell‐mediated immunopathology These findings underscore necessity further research unravel complexities enhance formulations broad protection maximum safety.

Язык: Английский

Процитировано

6

Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies DOI Creative Commons
Chunye Zhang, Yuxiang Sui, Shuai Liu

и другие.

Pharmaceuticals, Год журнала: 2023, Номер 16(10), С. 1479 - 1479

Опубликована: Окт. 17, 2023

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection drove the global coronavirus disease 2019 (COVID-19) pandemic, causing a huge loss of human life and negative impact on economic development. It is an urgent necessity to explore potential drugs against viruses, such as SARS-CoV-2. Silymarin, mixture herb-derived polyphenolic flavonoids extracted from milk thistle, possesses potent antioxidative, anti-apoptotic, anti-inflammatory properties. Accumulating research studies have demonstrated killing activity silymarin dengue virus, chikungunya hepatitis C virus. However, anti-COVID-19 mechanisms remain unclear. In this study, multiple disciplinary approaches methodologies were applied evaluate anti-viral agent SARS-CoV-2 infection. silico molecular docking, network pharmacology, bioinformatic methods incorporated assess ligand–protein binding properties analyze protein–protein interaction network. DAVID database was used gene functions, Kyoto Encyclopedia Genes Genomes (KEGG) pathway Gene Ontology (GO) enrichment. TCMSP GeneCards identify drug target genes COVID-19-related genes. Our results revealed that compounds, silybin A/B silymonin, displayed triplicate functions infection, including directly with angiotensin-converting enzyme 2 (ACE2) inhibit entry into host cells, viral proteins RdRp helicase replication proliferation, regulating immune response indirectly Specifically, targets molecules in regulation screened out, proinflammatory cytokines TNF IL-6 cell growth factors VEGFA EGF. addition, mechanism drug-target protein investigated, pockets ACE2 proteins, formation hydrogen bonds, hydrophobic interactions, other drug–protein ligand interactions. Finally, drug-likeness candidate passed criteria for screening. Overall, study demonstrates

Язык: Английский

Процитировано

7

Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates DOI Creative Commons

Chaim A. Schramm,

Damee Moon, Lowrey Peyton

и другие.

Nature Communications, Год журнала: 2023, Номер 14(1)

Опубликована: Дек. 2, 2023

Abstract As SARS-CoV-2 variants continue evolving, testing updated vaccines in non-human primates remains important for guiding human clinical practice. To date, such studies have focused on antibody titers and antigen-specific B T cell frequencies. Here, we extend our understanding by integrating innate adaptive immune responses to mRNA-1273 vaccination rhesus macaques. We sorted cells from a pre-vaccine time point, as well peripheral two weeks after each of vaccine doses used single-cell sequencing assess the transcriptomes receptors cell. show that subset S-specific expresses cytokines critical activating responses, with concomitant increase CCR5-expressing intermediate monocytes shift natural killer more cytotoxic phenotype. The second dose, administered 4 first, elicits an circulating germinal center-like 2 later, which are clonally expanded enriched epitopes receptor binding domain. Both stimulate inflammatory response genes associated elevated production. Overall, provide comprehensive picture bidirectional signaling between components system suggest potential mechanisms enhanced secondary exposure.

Язык: Английский

Процитировано

7

Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells? DOI Creative Commons

Stephanie Longet,

Stéphane Paul

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Сен. 11, 2023

OPINION article Front. Immunol., 11 September 2023Sec. Immunological Memory Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1216402

Язык: Английский

Процитировано

3